Therefore, it is necessary to conduct in-depth mechanism exploration in future to help reveal the role of CBFβ::MYH11 and RUNX1::RUNX1T1 in AML progression and their association with prognosis. Here, RUNX1T1 is linked to acute myeloid leukemia.